US 11464764
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted A61KA61K31/437A61K47/10
Quick answer
US patent 11464764 (Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound) held by Corcept Therapeutics Incorporated expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/437, A61K47/10, A61K47/14, A61K47/22